Organophosphate Poisoning

• FDA approval · 2015-02-03
  FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)

  The FDA approved a supplemental application for the ATNAA atropine and pralidoxime chloride auto-injector, updating/expanding its labeling.

• FDA approval · 2015-01-20
  FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)

  FDA approved a supplemental application for the ATNAA atropine and pralidoxime chloride auto-injector (Meridian) under NDA021175.

• FDA approval · 2014-05-15
  FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)

  FDA approved a supplemental application for the ATNAA atropine and pralidoxime chloride auto-injector from Meridian Medical Technologies, af…

• FDA approval · 2014-01-15
  FDA Approved: PROTOPAM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for PROTOPAM CHLORIDE (pralidoxime chloride) by Baxter Healthcare Corporation. This action updates t…

• FDA approval · 2013-11-14
  FDA Approved: ATROPEN AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies LLC)

  FDA approved a supplemental application for the ATROPEN AUTO-INJECTOR (atropine) by Meridian Medical Technologies LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2013-05-03
  FDA Approved: PROTOPAM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

  The FDA approved a supplemental application for Protopam Chloride (pralidoxime chloride) submitted by Baxter Healthcare Corporation. The act…

• FDA approval · 2013-04-09
  FDA Approved: DUODOTE — Supplemental Application (Meridian Medical Technologies LLC)

  The FDA approved a supplemental application for DUODOTE (atropine and pralidoxime chloride) by Meridian Medical Technologies LLC. The action…

• FDA approval · 2012-11-30
  FDA Approved: PROTOPAM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for PROTOPAM CHLORIDE (pralidoxime chloride) from Baxter Healthcare Corporation.

• FDA approval · 2010-09-08
  FDA Approved: PROTOPAM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

  The FDA approved a Baxter Healthcare supplemental application for Protopam Chloride (pralidoxime chloride), potentially updating labeling an…

• FDA approval · 2006-09-28
  FDA Approved: DUODOTE — Original Application (Meridian Medical Technologies LLC)

  FDA approved DUODOTE, a dual-auto-injector containing atropine and pralidoxime chloride, for emergency treatment of organophosphate poisonin…